Free Newsletter
| Get the pharma industry's daily monitor, with a special focus on pharmaceutical company news and the market development of FDA approved products. Sign up for free today! |
Wal-Mart boosts $4 generic program
The march of the generics continues. Wal-Mart says it's adding 24 new meds to its line-up of $4 prescriptions, including drugs for glaucoma, attention deficient hyperactivity disorder, and fungal infections. Plus, certain fertility and birth control drugs will be available for $9.
Since Wal-Mart unveiled the $4 program last fall, it has come to account for 40 percent of prescriptions filled at the company's pharmacies. A Wal-Mart official says the current list of $4 drugs is "scratching the surface" and that more will likely be added.
The company's also pledging to get new-to-market generics on the list lickety-split. Witness the generic form of Coreg, which was just approved by the FDA--it's already on the list.
- check out Wal-Mart's press release
- read the article from Newsday
Related Articles:
Generics beat down drug price inflation. Report
Wal-Mart slashing generic prices. Report
Wal-Mart expands $4 drug program, Target follows. Report
Should Wal-Mart go into the healthcare business? Report
Comments
Post new comment
Paid Research Reports
- RNA therapy: the next big thing after monoclonal antibodies?
- Biotech M&A Strategies: Deal assessments, trends and future prospects
- The Dermatology Market Outlook to 2013: Competitive landscape, pipeline analysis and growth opportunities
- Pipeline Insight: Cancer Overview - Breast, Gynecological, Genitourinary - Diverse drugs approaching the market for many tumor t
- Sales Force Effectiveness


